financially broke because of our funds being invested in a wet dream for a product which we see today is not on anyone's horizon (TAVR)
It was immunotherapies HSV2 that have been the black hole for money. Now hived off and not before time.
TAVR is at market elsewhere, it's our better tech with the improved valve that's the opportunity commercially.
Why say it's not on anyone's horizon? Surely it's valuable for any future partner/investor in terms of future revenue. Are you sure we would have gained no interest in this or even have had competing bids? No FOMO at all?
and now we are unable to make the necessary investment in Adapt.
oh well. let's wait and see?.
financially broke because of our funds being invested in a wet...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |